Protease Inhibitors

HSP-990 is an inhibitor of human heat-shock protein 90 (Hsp90) with potential antineoplastic activity. Hsp-990 binds to and inhibits the activity of Hsp90, which may result in the proteasomal degradation of oncogenic client proteins, including

HSP-990 is an inhibitor of human heat-shock protein 90 (Hsp90) with potential antineoplastic activity. Hsp-990 binds to and inhibits the activity of Hsp90, which may result in the proteasomal degradation of oncogenic client proteins, including

HSP-990 is an inhibitor of human heat-shock protein 90 (Hsp90) with potential antineoplastic activity. Hsp-990 binds to and inhibits the activity of Hsp90, which may result in the proteasomal degradation of oncogenic client proteins, including

Chemerin Recombinant Protein is suitable as a control for polyclonal or monoclonal anti-Chemerin in immunological assays.

Chemerin Recombinant Protein is suitable as a control for polyclonal or monoclonal anti-Chemerin in immunological assays.

Chemerin Recombinant Protein is suitable as a control for polyclonal or monoclonal anti-Chemerin in immunological assays.

Chemerin Recombinant Protein is suitable as a control for polyclonal or monoclonal anti-Chemerin in immunological assays.

NAP-2, CXCL7, human: Neutrophil Activating Peptide 2 (NAP-2) is proteolytically processed carboxyl-terminal fragments of platelet basic protein (PBP) which is found in the alpha-granules of human platelets. NAP-2 is a member of the CXC chemokines.

A synthetic compound which interacts with BET proteins with high-affinity (Kd = 32.5-42.

A synthetic compound which interacts with BET proteins with high-affinity (Kd = 32.5-42.

A synthetic compound which interacts with BET proteins with high-affinity (Kd = 32.5-42.

A synthetic compound which interacts with BET proteins with high-affinity (Kd = 32.5-42.